5:59 PM
 | 
Jan 14, 2013
 |  BC Extra  |  Financial News

Aileron closes $12M in second tranche of series D

Aileron Therapeutics Inc. (Cambridge, Mass.) closed $12 million in the second tranche of a $42 million series D round. Existing investors Apple Tree Partners; Excel Venture Management;...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >